Kristen N. Ruby, D.O., M.P.H.

  1. Tatake IJ, Wilkinson SC, Ruby KN, Collins JN, Dzik WH, Uhl L, Stowell S, Langer A, Makar RS, Carney BJ, Bendapudi PK. Determinants and clinical impact of time to plasma exchange in patients with immune thrombotic thrombocytopenic purpura. Transfusion. 2025 May 26 [Epub ahead of print]
    View PubMed
  2. Dzik WH, Ruby K, Brunker PAR, Collins J, Paik HI, Makar R. Auditing plasma transfusion in intensive care: Use of decision time interval analysis. Am J Clin Pathol. 2024 Sep 3; 162 (3):289-296
    View PubMed
  3. Dzik WS, Healy B, Brunker P, Ruby K, Collins J, Paik HI, Berra L, Shelton K, North CM, Makar R. Platelet transfusion in critical care: A new method to analyze transfusion practice based on decision time intervals. Transfusion. 2023 Sep; 63 (9):1661-1676 Epub 2023 Aug 22
    View PubMed
  4. Ruby KN, Dzik WH, Collins JJ, Eliason K, Makar RS. Emergency transfusion with whole blood versus packed red blood cells: A study of 1400 patients. Transfusion. 2023 Apr; 63 (4):745-754 Epub 2023 Feb 10
    View PubMed
  5. Ruby KN, Khan J, Martin IW, Dunbar NM. Application of Standardized Residual Component Culture Criteria for Suspected Septic Transfusion Reactions Would Increase the Component Culturing Rate at a Single Academic Medical Center. Am J Clin Pathol. 2022 Aug 4; 158 (2):216-220
    View PubMed
  6. Ruby KN, Harm SK, Dunbar NM. Risk of ABO-Incompatible Plasma From Non-ABO-Identical Components. Transfus Med Rev. 2021 Oct; 35 (4):118-122 Epub 2021 Aug 25
    View PubMed
  7. Ruby KN, Li Z, Yan S. Aberrant expression of HMB45 and negative PRAME expression in halo nevi. J Cutan Pathol. 2021 Apr; 48 (4):519-525 Epub 2020 Nov 25
    View PubMed
  8. Ruby KN. Remembering Acute Myeloid Leukemia with Myelodysplasia-Related Changes. Clin Chem. 2020 Sep 1; 66 (9):1254-1255
    View PubMed
  9. Jackson CR, Sriharan A, Momtahen S, Seidel GD, Felty CC, Ruby KN, Yan S. Melanocytic aggregates with unique morphology associated with regression of basal cell carcinoma. J Cutan Pathol. 2020 Mar; 47 (3):219-225 Epub 2019 Nov 23
    View PubMed
  10. Ruby KN, Loo EY, Mann JA, LeBlanc RE. Post-scabietic nodules: Mimicker of infantile indeterminate cell histiocytosis and potential diagnostic pitfall. J Cutan Pathol. 2020 Jan; 47 (1):52-56 Epub 2019 Aug 25
    View PubMed
  11. Ruby KN, Liu CL, Li Z, Felty CC, Wells WA, Yan S. Diagnostic and prognostic value of glucose transporters in melanocytic lesions. Melanoma Res. 2019 Dec; 29 (6):603-611
    View PubMed
  12. Ruby KN, Thomasson RR, Szczepiorkowski ZM, Dunbar NM. Bacterial screening of apheresis platelets with a rapid test: a 113-month single center experience. Transfusion. 2018 Jul; 58 (7):1665-1669 Epub 2018 Apr 17
    View PubMed
  13. Ruby KN, Deng AC, Zhang J, LeBlanc RE, Linos KD, Yan S. Emperipolesis and S100 expression may be seen in cutaneous xanthogranulomas: A multi-institutional observation. J Cutan Pathol. 2018 May 24 [Epub ahead of print]
    View PubMed
  14. Ruby K, Falvey K, Kulesza RJ. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats. Neuroscience. 2015 Sep 10; 303:285-98 Epub 2015 July 09
    View PubMed
  15. Stansfield KH, Ruby KN, Soares BD, McGlothan JL, Liu X, Guilarte TR. Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia. Transl Psychiatry. 2015 Mar 10; 5 (3):e522
    View PubMed